Heron Therapeutics (HRTX) Change in Inventory (2016 - 2026)
Heron Therapeutics' (HRTX) quarterly Change in Inventory came in at $169000.0 in Q1 2026, down 95.52% YoY from $3.8 million in Q1 2025, and down 98.81% on a QoQ basis from $14.2 million in Q4 2025.
Heron Therapeutics (HRTX) Change in Inventory (2016 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 11 years of Change in Inventory data on file, last reported at $169000.0 in Q1 2026.
- Quarterly Change in Inventory fell 95.52% year-over-year to $169000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.4 million (up 89.84% YoY) and the FY2025 annual result came in at $31.1 million, up 181.01% from the prior year.
- Change in Inventory eased to $169000.0 in Q1 2026, from $14.2 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $16.0 million in Q2 2025 to a low of -$9.1 million in Q3 2022.
- A 5-year average of $2.1 million and a median of $391000.0 in 2024 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory tumbled 599.46% — and 2024, when it jumped 6900.0%.
- Tracing HRTX's Change in Inventory over 5 years: stood at $2.3 million in 2022, then slumped by 95.59% to $103000.0 in 2023, then jumped by 6900.0% to $7.2 million in 2024, then jumped by 96.77% to $14.2 million in 2025, then tumbled by 98.81% to $169000.0 in 2026.
- The last three Change in Inventory figures came in at $169000.0 (Q1 2026), $14.2 million (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Heron Therapeutics | 59.96 Mn | 17.29 Mn | 26.09 Mn | 683,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 683,000.00 |
| Jun 30, 2026 | 683,000.00 |
| Mar 31, 2026 | 169,000.00 |
| Mar 31, 2026 | 169,000.00 |
| Dec 31, 2025 | 14.19 Mn |
| Dec 31, 2025 | 14.19 Mn |
| Sep 30, 2025 | -2.94 Mn |
| Sep 30, 2025 | -2.94 Mn |
| Jun 30, 2025 | 16.03 Mn |
| Jun 30, 2025 | 16.03 Mn |
| Mar 31, 2025 | 3.77 Mn |
| Mar 31, 2025 | 3.77 Mn |
| Dec 31, 2024 | 7.21 Mn |
| Dec 31, 2024 | 7.21 Mn |
| Sep 30, 2024 | 3.09 Mn |
| Sep 30, 2024 | 3.09 Mn |
| Jun 30, 2024 | 391,000.00 |
| Jun 30, 2024 | 391,000.00 |
| Mar 31, 2024 | 363,000.00 |
| Mar 31, 2024 | 363,000.00 |